Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Cilia- and flagella-associated protein 90 (CFAP90) is a human protein encoded by the CFAP90 gene (previously known as C5orf49, LOC134121), primarily localized within the axoneme and ciliary basal body of motile cilia and flagella[3][5][7]. It functions as a microtubule inner protein (MIP) critical for the integrity and proper beating of motile cilia, contributing to processes such as sperm motility and possibly the movement of fluid across ciliated epithelia[3][2][7]. Mutations in CFAP90 have been associated with disorders such as lacrimal duct obstruction and cone-rod dystrophy 18, highlighting its role in ciliary structure and function[3]. Currently, CFAP90 is not recognized as a druggable therapeutic target or used as a biomarker. No drug interactions or clinical mechanisms are reported, and it is best classified as an essential component of the molecular machinery of the ciliary axoneme, with a primary structural and motility role rather than as an enzyme, transporter, receptor, or transcription factor[3][7].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Cilia- and flagella-associated protein 90 (CFAP90).